Ronald Kirk Huntsman

VVOS

Ronald Kirk Huntsman serves as Chief Executive Officer at Vivos Therapeutics, Inc. (VVOS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

7 trades

$112.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$112.0K

Companies Traded

VVOS

Active Period

May 2021 – Jun 2023

7 total trades

Most Recent

Buy VVOS

Jun 20, 2023 · $15.5K

Ronald Kirk Huntsman's Insider Trading at Vivos Therapeutics, Inc. (VVOS)

Buys

7 · $112.0K

Sells

0 · $0.00

Total Shares Bought

85,021

Total Shares Sold

VVOS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 20, 2023	Buy	29,021	$0.53	$15.5K	86,521
Jun 15, 2023	Buy	10,000	$0.49	$4.9K	57,500
Dec 28, 2022	Buy	20,000	$0.50	$10.0K	47,500
Jun 3, 2022	Buy	12,000	$1.96	$23.6K	27,500
Sep 22, 2021	Buy	5,000	$4.31	$21.6K	15,500
Aug 18, 2021	Buy	5,000	$3.00	$15.0K	10,500
May 25, 2021	Buy	4,000	$5.38	$21.5K	5,500

Related Insiders

Michael C Skaff

10 percent owner

VVOSBuy · Jul 15, 2026

Explore More Insider Trading Data

VVOS Insider Trading Activity

View all insider trades at Vivos Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity